Early Retirement Portfolio: Top 15 Stock Picks

Page 9 of 15

7. Bristol-Myers Squibb Company (NYSE:BMY)

Dividend Yield: 5.29%

Number of Hedge Fund Holders: 69

Bristol-Myers Squibb Company (NYSE:BMY) ranks among the top stocks for an early retirement portfolio. On June 12, Cantor Fitzgerald maintained its price target of $55 and its rating of Neutral for Bristol-Myers Squibb Company (NYSE:BMY).

The company’s Cobenfy’s ADEPT-2 top-line data in Alzheimer’s Disease Psychosis is anticipated in 2025, possibly as early as the second half of that year. According to Cantor Fitzgerald, this information reflects “the highest-impact remaining catalyst for BMY shares this year.”

Cantor believes that Cobenfy will surpass Opdivo and Reblozyl as the company’s third-largest-selling medicine by 2030, making the treatment crucial to Bristol-Myers’ future revenue profile.

Despite its potential significance, Cantor Fitzgerald characterized ADEPT-2 as “challenging to handicap” because of the varied older group being treated, the lack of clinical data, and the substantial heterogenous in neuropsychiatric investigations.

Bristol-Myers Squibb Company (NYSE:BMY) is a global biopharmaceutical company that discovers, produces, and supplies prescription medications for severe illnesses in fields including cancer, hematology, immunology, cardiovascular disease, and neuroscience.

Page 9 of 15